Atlas Trials

NSCLC, Recurrent

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch NSCLC, Recurrent

RecordFirmDate
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC (NCT04467723)University of Kansas Medical Center2022-05-18
A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451)Lyell Immunopharma, Inc.2022-03-29
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC (NCT04768491)Peking Union Medical College2020-09-01
Prospective Observation of Failure Patterns in NSCLC Treated With ICIs (NCT04492969)Fudan University2020-09-01
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC) (NCT04636775)Jun Zhang, MD, PhD2020-07-29
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma (NCT03361319)Royal Marsden NHS Foundation Trust2020-07-01
Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions (NCT03805841)Rain Oncology Inc2019-03-13
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations (NCT05701787)Shanghai Chest Hospital2019-01-01
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer (NCT03713944)Nasser Hanna2018-11-15

Track NSCLC, Recurrent automatically

Every clearance here is in the API, with alerts when new ones post.